Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats

American Journal of Hypertension

Volumn 24, Issue 6, 2011, Pages 724-730

  Gao, Juan ^a   Zhang, Hao ^a   Le, Khang D ^a   Chao, Jie ^a   Gao, Lie ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

angiotensin type 2 receptor; blood pressure; central nervous system; hypertension; norepinephrine; potassium current

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; COMPOUND 21; HORMONE RECEPTOR STIMULATING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BRAIN CORTEX; CONSCIOUSNESS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME IMMUNOASSAY; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MALE; MEDULLA OBLONGATA; NONHUMAN; NORADRENALIN RELEASE; NORADRENALIN URINE LEVEL; OSMOTIC PUMP; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOLITARY TRACT NUCLEUS; TELEMETRY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; IMIDAZOLES; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; NOREPINEPHRINE; POTASSIUM; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 2; SULFONAMIDES;

EID: 79956120211     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.33     Document Type: Article

References (30)

1. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 2003; 12:70-88. (Pubitemid 36700689)
2. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-472.
3. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol, Cell Physiol 2007; 292:C82-C97. (Pubitemid 46127306)
4. Touyz RM, Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 2002; 35:1001-1015. (Pubitemid 35452880)
5. Sumners C, Gelband CH. Neuronal ion channel signalling pathways: modulation by angiotensin II. Cell Signal 1998; 10:303-311. (Pubitemid 28286786)
6. Gelband CH, Sumners C, Lu D, Raizada MK. Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Regul Pept 1997; 72:139-145. (Pubitemid 28053870)
7. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA 1999; 96:6506-6510. (Pubitemid 29256696)
8. Li Z, Iwai M, Wu L, Shiuchi T, Jinno T, Cui TX, Horiuchi M. Role of AT2 receptor in the brain in regulation of blood pressure and water intake. Am J Physiol Heart Circ Physiol 2003; 284:H116-H121. (Pubitemid 36076277)
9. Gao L, Wang WZ, Wang W, Zucker IH. Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension 2008; 52:708-714.
10. Gao L, Wang W, Wang W, Li H, Sumners C, Zucker IH. Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats. Hypertension 2008; 51:521-527. (Pubitemid 351156442)
11. Yu L, Zheng M, Wang W, Rozanski GJ, Zucker IH, Gao L. Developmental changes in AT1 and AT2 receptor-protein expression in rats. J Renin Angiotensin Aldosterone Syst 2010; 11:214-221.
12. Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam AK, Wu X, Johansson B, Holm M, Botoros M, Karlén A, Pettersson A, Nyberg F, Fändriks L, Gallo-Payet N, Hallberg A, Alterman M. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004; 47:5995-6008. (Pubitemid 39507341)
13. Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, Sommerfeld M, Kemnitz UR, Curato C, Namsolleck P, Tschöpe C, Hallberg A, Alterman M, Hucko T, Paetsch I, Dietrich T, Schnackenburg B, Graf K, Dahlöf B, Kintscher U, Unger T, Steckelings UM. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 2008; 118:2523-2532.
14. Bosnyak S, Welungoda IK, Hallberg A, Alterman M, Widdop RE, Jones ES. Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol 2010; 159:709-716.
15. Palkovits M, Brownstein MJ. Maps and Guide to Microdissection of the Rat Brain. Elsevier Science Publishing Co., Inc.: New York, New York, 1988.
16. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Compact 3rd edn. Academic Press, Inc.: San Diego, California, 1997.
17. Lu N, Helwig BG, Fels RJ, Parimi S, Kenney MJ. Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II. Am J Physiol Heart Circ Physiol 2004; 287:H2626-H2633. (Pubitemid 39557133)
18. Bowers CW, Baldwin C, Zigmond RE. Sympathetic reinnervation of the pineal gland after postganglionic nerve lesion does not restore normal pineal function. J Neurosci 1984; 4:2010-2015. (Pubitemid 14025563)
19. Takekoshi K, Ishii K, Isobe K, Nanmoku T, Kawakami Y, Nakai T. Angiotensin-II subtype 2 receptor agonist (CGP-42112) inhibits catecholamine biosynthesis in cultured porcine adrenal medullary chromaffin cells. Biochem Biophys Res Commun 2000; 272:544-550. (Pubitemid 30444653)
20. Kang J, Sumners C, Posner P. Angiotensin II type 2 receptor-modulated changes in potassium currents in cultured neurons. Am J Physiol 1993; 265:C607-C616.
21. Kang J, Richards EM, Posner P, Sumners C. Modulation of the delayed rectifier K+ current in neurons by an angiotensin II type 2 receptor fragment. Am J Physiol 1995; 268:C278-C282.
22. Martens JR, Wang D, Sumners C, Posner P, Gelband CH. Angiotensin II type 2 receptor-mediated regulation of rat neuronal K+ channels. Circ Res 1996; 79: 302-309. (Pubitemid 26255883)
23. Matsuura T, Kumagai H, Onimaru H, Kawai A, Iigaya K, Onami T, Sakata K, Oshima N, Sugaya T, Saruta T. Electrophysiological properties of rostral ventrolateral medulla neurons in angiotensin II 1a receptor knockout mice. Hypertension 2005; 46:349-354. (Pubitemid 41099168)
24. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998; 83:1182-1191. (Pubitemid 29006033)
25. Nouet S, Nahmias C. Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol Metab 2000; 11:1-6. (Pubitemid 30395452)
26. Zhao Y, Biermann T, Luther C, Unger T, Culman J, Gohlke P. Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. J Neurochem 2003; 85:759-767. (Pubitemid 36531939)
27. Gendron L, Oligny JF, Payet MD, Gallo-Payet N. Cyclic AMP-independent involvement of Rap1/B-Raf in the angiotensin II AT2 receptor signaling pathway in NG108-15 cells. J Biol Chem 2003; 278:3606-3614. (Pubitemid 36801084)
28. Côté F, Laflamme L, Payet MD, Gallo-Payet N. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr Res 1998; 24:403-407. (Pubitemid 29016414)
29. Prast H, Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol 2001; 64:51-68. (Pubitemid 32201889)
30. Han NL, Ye JS, Yu AC, Sheu FS. Differential mechanisms underlying the modulation of delayed-rectifier K+ channel in mouse neocortical neurons by nitric oxide. J Neurophysiol 2006; 95:2167-2178.